Immunicum AB (DE:1YG0)
FRANKFURT:1YG0
Germany Market
Holding DE:1YG0?
Track your performance easily

Immunicum AB (1YG0) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Immunicum AB’s (1YG0) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Immunicum AB is a Buy.
Immunicum AB’s (1YG0) 20-Day exponential moving average is 0.81, while Immunicum AB’s (1YG0) share price is €0.823, making it a Buy.
Immunicum AB’s (1YG0) 50-Day exponential moving average is 0.75, while Immunicum AB’s (1YG0) share price is €0.823, making it a Buy.

Immunicum AB (1YG0) Pivot Points

Nov 13, 2024, 11:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.84
0.84
0.84
0.84
0.84
0.84
0.84
Fibonacci
0.84
0.84
0.84
0.84
0.84
0.84
0.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunicum AB (1YG0) Moving Averages

Nov 13, 2024, 11:28 PM
Period
Simple
Exponential
MA5
0.84Sell
0.84Sell
MA10
0.85Sell
0.84Sell
MA20
0.80Buy
0.81Buy
MA50
0.73Buy
0.75Buy
MA100
0.71Buy
0.71Buy
MA200
0.62Buy
0.65Buy
Immunicum AB’s (1YG0) 10-Day exponential moving average is 0.84, while Immunicum AB’s (1YG0) share price is €0.823, making it a Sell.
Immunicum AB’s (1YG0) 100-Day exponential moving average is 0.71, while Immunicum AB’s (1YG0) share price is €0.823, making it a Buy.
Immunicum AB’s (1YG0) stock price is €0.823 and Immunicum AB’s (1YG0) 50-day simple moving average is 0.73, creating a Buy signal.
Immunicum AB’s (1YG0) stock price is €0.823 and Immunicum AB’s (1YG0) 100-day simple moving average is 0.71, creating a Buy signal.
Immunicum AB’s (1YG0) stock price is €0.823 and Immunicum AB’s (1YG0) 200-day simple moving average is 0.62, creating a Buy signal.

Immunicum AB (1YG0) Technical Indicators

Nov 13, 2024, 11:28 PM
Name
Value
Implied Action
RSI (14)
56.25
Neutral
STOCH (9,6)
24.03
Neutral
STOCHRSI (14)
79.67
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
27.68
Neutral
Williams %R
-31.71
Buy
CCI (14)
21.93
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
38.09
Neutral
ROC
20.59
Buy
Immunicum AB’s (1YG0) Relative Strength Index (RSI) is 56.25, creating a Neutral signal.
Immunicum AB’s (1YG0) Trend Strength Indicator (ADX) is 27.68, creating a Neutral signal.
Immunicum AB’s (1YG0) Commodity Channel Index (CCI) is 21.93, creating a Neutral signal.
Immunicum AB’s (1YG0) Price Rate of Change (ROC) is 20.59, creating a Buy signal.

FAQ

Is 1YG0 a Buy, Hold, or Sell?
Based on 1YG0’s technical indicators, 1YG0 is a Buy.
    What is 1YG0’s RSI (14)?
    1YG0’s RSI (14) is 56.25, which suggests 1YG0 is a Neutral.
      What is 1YG0’s MACD?
      1YG0’s MACD is 0.04, which suggests 1YG0 is a Buy.
        What is 1YG0’s 5-day moving average?
        1YG0’s 5-day moving average is 0.84, which suggests 1YG0 is a Sell.
          What is 1YG0’s 20-day moving average?
          1YG0 20-day moving average is 0.80, which suggests 1YG0 is a Buy.
            What is 1YG0’s 50-day moving average?
            1YG0’s 50-day moving average is 0.73, which suggests 1YG0 is a Buy.
              What is 1YG0’s 200-day moving average?
              1YG0’s 200-day moving average is 0.62, which suggests 1YG0 is a Buy.
                What is 1YG0’s Williams % R (14)?
                1YG0’s Williams % R (14) is -31.71, which suggests 1YG0 is a Buy.
                  What is 1YG0’s CCI (14)?
                  1YG0’s CCI (14) is 21.93, which suggests 1YG0 is a Neutral.
                    What is the share price of Immunicum AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis